May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
Impact of Exposure to Benzalkonium Chloride on Corneal Mucin
Author Affiliations & Notes
  • S.–H. Chung
    Ophthalmology, Yonsei University, Institute of vision research, Seoul, Republic of Korea
  • S.K. Lee
    Ophthalmology, Yonsei University, Institute of Vision Research, Seoul, Republic of Korea
  • J.H. Lee
    Ophthalmology, Yonsei University, Institute of Vision Research, Seoul, Republic of Korea
  • K.Y. Seo
    Ophthalmology, Yonsei University, Institute of Vision Research, Seoul, Republic of Korea
  • S.J. Lee
    Ophthalmology, Yonsei University, Institute of Vision Research, Seoul, Republic of Korea
  • E.K. Kim
    Ophthalmology, Yonsei University, Institute of Vision Research, Seoul, Republic of Korea
  • Footnotes
    Commercial Relationships  S. Chung, None; S.K. Lee, None; J.H. Lee, None; K.Y. Seo, None; S.J. Lee, None; E.K. Kim, None.
  • Footnotes
    Support  Korea Health 21 R&D Project 02–PJ1–PG1–CH02–0003
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 3499. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S.–H. Chung, S.K. Lee, J.H. Lee, K.Y. Seo, S.J. Lee, E.K. Kim; Impact of Exposure to Benzalkonium Chloride on Corneal Mucin . Invest. Ophthalmol. Vis. Sci. 2005;46(13):3499.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To investigate the effect of one of the most frequently used preservative, benzalkonium chloride (BAC), on transmembranous mucin, and MUC1 and MUC16 in immortalized corneal cells and pre–corneal mucous layer in the rabbit corneal epithelium. Methods: Immortalized corneal cells (HCLE) were incubated for 15 minutes in 6 different conditions and expression of MUC1 and MUC16 were compared by western blotting: 1) serum–free media as a control group 2) 0.01% BAC 3) commercially available ocuflox® antibiotic eyedrop (0.3% ofloxacin with 0.0025% BAC) 4) 0.3% ofloxacin 5) commercially available topical alcaine® anesthetic eyedrop (0.5% proparacaine with 0.01% BAC) 6) 0.5% proparacaine. Healthy female albino rabbits were euthanised at 15.00 hours. The dissected corneas were treated with 0.01% BAC over a period of 1, 5, 10, 15, 30 and 60 minutes, and fixed with buffered glutaraldehyde fixative PH 7.4 at 35°C with tannic acid staining. As a control group, cornea was immediately fixed with buffered glutaraldehyde fixative. Specimens of cornea were critical point dried out of propylene oxide and embedded in Epon. The sectioned materials were examined by transmission electron microscopy (TEM). Results: The expression of MUC1 and MUC16 in group treated with 0.01% BAC was decreased compare to that of the control group that was incubated with serum–free media. Also the expression of MUC1 and MUC16 in two groups treated with commercially available eyedrops were decreased compare to that of their separate agents: 0.3% ofloxacin and 0.5% proparacaine. Specimens treated with 0.01% BAC from over a period of 5 minutes to 60 minutes showed dense mucous layer. However, little or no mucus were retained on the surface of cornea in control and treated for 1–minute groups. Conclusions: Commercially available ocuflox® antibiotic eyedrop, alcaine® anesthetic eyedrop and BAC decreased the expression of MUC1 and MUC16 in immortalized corneal cells. With the treatment of 0.01% BAC even for 5 minutes, dense mucous layer was evident on the corneal surface by TEM. These changes would prevent membranous mucin, MUC1 and MUC 16, from properly working resulting unstable tear film and dry eye symptoms.

Keywords: cornea: epithelium • drug toxicity/drug effects 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×